Main Article Content

Joseph Miller


Sarcopenia, Older Adults, Screening Procedures, Physical Function


Objective: Sarcopenia is defined as a progressive, generalized loss of skeletal muscle mass and strength. Early detection with screening procedures is thought to be a key to mitigating the damage of sarcopenia. Sarcopenia often goes unrecognized in primary health care settings. Chiropractors are uniquely positioned to play an important role in screening this condition. The purpose of this paper is to review the evidence assessing the validity and usefulness of 5 commonly applied sarcopenia screening tools for use in clinical settings.

Methods: MEDLINE, PubMed, Scopus and Google Scholar searches were conducted to identify relevant papers published between 1985-2021. Three questions drove this review: what is the prevalence of sarcopenia; what are the potential health consequences of sarcopenia; and, what screening tools are available for the early detection of sarcopenia.

Results: Papers were screened according to the following eligibility criteria. Population: community dwelling adults aged 40 and over; men and women screened for sarcopenia with clear-cut diagnostic criteria. Studies were included in the review if they were RCT’s, reviews or guidelines. Limits: English language, human adults. Of Of 3,224 records a total of 36 papers were included in this review. Although researchers generally are in agreement of the need for screening tools to identify sarcopenia in clinical settings, there is no consensus about which screening tools are most useful at performing this task.

Conclusions: This paper presents evidence on the predictive value of five screening tools for sarcopenia. This data has importance to chiropractors who by their practice privileges are uniquely positioned to detect patients at risk for sarcopenia with use of viable screening tools. Although more research is needed to determine the most effective screening tools for sarcopenia, utilization of these procedures, by chiropractors, may be valuable in helping to mitigate health consequences related to sarcopenia.


Download data is not yet available.
Abstract 1342 | SARCOPENIA Downloads 168


1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39(4):412-423

2. Chen LK, Liu LK, Woo J et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95-101

3. Chumlea WC, Cesari M, Evans WJ et al. International Working Group on Sarcopenia. J Nut Hlth Aging 2011;15:450-455

4. Hanna JS. Sarcopenia and critical illness: A deadly combination in the elderly. L Parenter Enteral Nutr 2015;39(3):273-281

5. Landi F, Liperoti R, Russo A et al. Sarcopenia as a risk factor for falls in elderly individuals. Results for the iISIRENTE Study Cl Nut 2012;31(5):652-658

6. Cramer JT, Cruz-Jentoft AJ, Landi F et al. Impacts of high-protein oral nutritional supplements among malnourished men and women with sarcopenia: A multi-center, randomized, double-blinded, controlled trial. J Am Med Dir Assoc 2016;17(11):1044-1055

7. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapena and impact of advancing age on human skeletal muscle size and strength. A quantative review. Front Physiol 2012;3:260-271

8. Verlaan S, Aspray TJ, Bauer JM et al. Nutritional status, body composition and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults. A case-control study. Clin Nut 2017:36(1):267-274

9. Dennison EM, Sayer AA, Cooper C. Epidemology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatal 2017:13(6):340-347

10. Peterson MD. Resistance exercise for sarcopenia outcomes and muscular fitness in aging adults. Nat Str Coach Assoc 2020:32(3):52-63

11. Dryer HC, Volpi E. Role of protein and amino acids in pathophysiology and treatment of sarcopenia. J Am Coll Nut 2005:24(2):140s-145s

12. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy older men and women. J Geront 2002;57(12):M772-M777

13. Robinson, SM, Reginster JY, Rizzoli R et al. Does nutrition play a role in prevention and management of sarcopenia. Cl Nut 2018;37(4):1121-1132

14. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. Sarcopenia. etiology, clinical consequences, intervention and assessment. Osteop 2010;21(4):543-559

15. Jannsen I. Influence of sarcopenia on development of physical disability. The Cardiovascular Health Study. J Am Geriatr Soc 2006;54:56-62

16. Martone AM, Marzetti E, Calvani R et al. Assessment of sarcopenia from clinical practice to research. JGG 2019;67:39-45

17. Lexall J. Human aging, muscle mass and fiber type composition. J Gerontol A Biol Sci Med Sci 1995;50A:11-16

18. Janssen I.The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004;52:80-85

19. Chen LK, Liu LK, Woo et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. 2014:15(2):95-101

20. Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR. Response of muscle protein anabolism to hyperaminoacidemia and glucose-induced hyperinsulinemia impaired in elderly. J Clin Endocrinol Metab 2000;85(12):4481-4490

21. Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia. Revised European consensus on definition and diagnosis. Age and Aging 2018;0:1-16

22. Malstrom TK, Morley JE. SARC-F a simple questionnaire to rapidly diagnosis sarcopenia. J Am Med Dir Assoc 2013;14(8):531-532

23. Woo J, Leung J, Morley JE. Validating the SARC-F. A suitable community screening tool for sarcopenia. J Am Med Dir Assoc 2014;15(9):630-634

24. Krzyminska-Siemaszko R, Tobis S, Lewandowicz, M et al. Comparision of four sarcopenia screening questionnaires in community-dwelling older adults for Poland using six sets of international diagnostic criteria for sarcopenia. Plos One 2020;15(4):1-16

25. Barbosa-Silva GT, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F. Improving sarcopenia screening in clinical practice. 2016;17(12):1136-1141

26. WHO Expert Committee on Physical Status: Use and interpretation of anthropometry. World Health Organization 1993;

27. Bahat G, Oren MM, Vilmaz O, et al. Comparing SARC-F with SARC-Calf to screen sarcopenia in community living older adults. J Nutr Health Aging 2018;22(9):1034-1038

28. Goodman MJ, Ghate SR, Mavros P, et al. Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cach Sarco Mus 2013;4:187-197

29. Locquest M, Beaudart C, Reginster JY, Peterman J, Broyere O. Comparision performance of five screening methods for sarcopenia. Clin Epid 2018;10:71-82

30. Liu, LK, Lee WJ, Liu CL, et al. Age related skeletal muscle mass loss and physical performance in Taiwan and implications to diagnostic strategy of sarcopenia in Asia. Geriatr Gerontol Int 2013;13(4):964-971

31. Linge J, Heymsfield SB, Leinhold OD. On the definition of sarcopenia in the presence of aging and obesity. Initial results from UK Biobank. J Gerontol 2020:75(7):1309-1316

32. Kurita N, Wakita T, Kamitani T, Wada O, Mizunu K. SARC-F validation and SARC-F EBM derivation in musculoskeletal disease. The SPSS-OK Study. J Nutr Health Aging 2019;23(8)732-738

33. Prince MJ, Wu F, Guo Y et al. The burden of disease in older people and implications for health policy and practice. Lancet 2015;385(9967):549-562

34. Kemmler W, Teschlea M, Goisser S, et al. Prevalence of sarcopenia in Germany and the corresponding effect of osteoarthritis in females 70 years and older. Clin Interv Aging 2015;10:1565-1573

35. Krzyminska-Siemaszko R, Deskur-Siemielecks E, Kaluzniak-Szymanowska A, et al. Comparision of diagnostic performance of SARC-F and two modified versions (SARC-Calf, SARC_F EBM) in community dwelling older adults in Poland. Clin Interv Aging 2020;15:583-594

36. Ishii S, Tanaka T, Shibasaki K, et al. Development of a single simple screening test for sarcopenia in older adults. Geriat Geront Int 2014;14(1):93-101